Market Overview

Jim Cramer Weighs In On Dropbox, Teva And More

Share:
Related SQM
31 Stocks Moving In Monday's Pre-Market Session
Earnings Scheduled For November 21, 2018
Related MYL
The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

On CNBC's "Mad Money Lightning Round", Jim Cramer said he would stay away from Sociedad Quimica y Minera de Chile (NYSE: SQM). He doesn't see any edge that could make him money in the stock.

Cramer prefers Mylan NV (NASDAQ: MYL) over Teva Pharmaceutical Industries Ltd ADR (NYSE: TEVA).

Linde PLC (NYSE: LIN) is going to be a powerhouse, says Cramer. He loves the industrial gas industry and he would buy the weakness.

Cramer is a buyer of Dropbox Inc (NASDAQ: DBX). He likes the story and he thinks the last report was great.

salesforce.com, inc. (NYSE: CRM) is one of the key positions for Cramer's charitable fund. He advised his viewers to own the stock.

Cramer is not a buyer of IQIYI Inc (NASDAQ: IQ).

Posted-In: CNBC Jim Cramer mad money Lightning RoundMedia

 

Related Articles (CRM + DBX)

View Comments and Join the Discussion!

Tide Could Be Turning For This Chip ETF

Alibaba, Cleveland-Cliffs, Dunkin Grands, JPMorgan Chase: 'Fast Money' Picks For November 14